Page last updated: 2024-08-24

ibopamine and cardiovascular agents

ibopamine has been researched along with cardiovascular agents in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brendel, E; de Mey, C; Enterling, D; Wesche, H1
Burri, M; Kehtari, R; Metzger, J; Reuge, L1
Poole-Wilson, PA; van Veldhuisen, DJ1

Reviews

2 review(s) available for ibopamine and cardiovascular agents

ArticleYear
[Chronic cardiac insufficiency: current treatment and future outlook].
    Revue medicale de la Suisse romande, 1996, Volume: 116, Issue:6

    Topics: Adrenergic Antagonists; Aldosterone; Angiotensin II; Cardiotonic Agents; Cardiovascular Agents; Clinical Protocols; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Vasoconstrictor Agents

1996
The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure.
    International journal of cardiology, 2001, Volume: 80, Issue:1

    Topics: Bosentan; Cardiovascular Agents; Deoxyepinephrine; Heart Failure; Humans; Imidazoles; Mibefradil; Pyrazines; Quinolines; Sulfonamides; Xamoterol

2001

Other Studies

1 other study(ies) available for ibopamine and cardiovascular agents

ArticleYear
Pharmacokinetics and pharmacodynamics of single oral doses of ibopamine, quinidine and their combination in normal man.
    European journal of clinical pharmacology, 1988, Volume: 34, Issue:4

    Topics: Adult; Cardiovascular Agents; Deoxyepinephrine; Dopamine; Drug Interactions; Electrocardiography; Humans; Male; Phonocardiography; Quinidine

1988